Literature DB >> 21587217

Medical oncology: Patients with brain metastases in early-phase trials.

Nicholas F Marko, Robert J Weil.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21587217     DOI： 10.1038/nrclinonc.2011.73

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

Review 1.  Envisioning the future of early anticancer drug development.

Authors:  Timothy A Yap; Shahneen K Sandhu; Paul Workman; Johann S de Bono
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

Review 2.  Brain metastases: a medical neuro-oncology perspective.

Authors:  Marc C Chamberlain
Journal:  Expert Rev Neurother       Date:  2010-04       Impact factor: 4.618

3.  The management of metastases to the brain by irradiation and corticosteroids.

Authors:  J Horton; D H Baxter; K B Olson
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1971-02

4.  Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases.

Authors:  Nicholas F Marko; Lilyana Angelov; Steven A Toms; John H Suh; Sam T Chao; Michael A Vogelbaum; Gene H Barnett; Robert J Weil
Journal:  World Neurosurg       Date:  2009-07-15       Impact factor: 2.104

5.  Phase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experience.

Authors:  Apostolia Maria Tsimberidou; Katherine Letourneau; Sijin Wen; Jennifer Wheler; David Hong; Aung Naing; Nancy G Iskander; Cynthia Uehara; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

6.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

Authors:  L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

7.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

Authors:  Paul W Sperduto; Samuel T Chao; Penny K Sneed; Xianghua Luo; John Suh; David Roberge; Amit Bhatt; Ashley W Jensen; Paul D Brown; Helen Shih; John Kirkpatrick; Amanda Schwer; Laurie E Gaspar; John B Fiveash; Veronica Chiang; Jonathan Knisely; Christina Maria Sperduto; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-26       Impact factor: 7.038

8.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

9.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321
  9 in total
  2 in total

Review 1.  Brain metastasis: new opportunities to tackle therapeutic resistance.

Authors:  Joan Seoane; Leticia De Mattos-Arruda
Journal:  Mol Oncol       Date:  2014-06-02       Impact factor: 6.603

2.  Clinical trial design in brain metastasis: approaches for a unique patient population.

Authors:  David M Peereboom
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.